Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Changes

19 Jan 2022 07:00

RNS Number : 8753Y
Experian plc
19 January 2022
 

Directorate Changes

 

19 January 2022  Experian, the global information services company, today announces that after 19 years at Experian, Kerry Williams has notified the Company of his intention to retire as Chief Operating Officer and as an Executive Director of the Company. To ensure a smooth succession process, Kerry will remain with Experian through to 31 March 2023.

 

Craig Boundy will succeed Kerry Williams. Craig has successfully led Experian's North America region for seven years, having joined Experian in November 2011 to lead the UK & Ireland region, and operated in a variety of leading management positions. Craig will assume the position of Chief Operating Officer on 1 April 2022 and will join the Board as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022, when Kerry will step down from the Board.

 

Jennifer Schulz will assume the role of CEO, North America for Experian from 1 April 2022. Jennifer joined Experian in 2013 and is currently Group President of our North America Health and Automotive businesses and global Targeting and Data Quality (EDQ) businesses.

 

Mike Rogers, Experian's Chairman said "Experian has made tremendous progress over the past few years and we are immensely grateful to Kerry for his outstanding contribution to this success. Craig's commercial and operational expertise, as well as his commitment to fostering diversity, equity and inclusion within Experian, will bring equally deep knowledge and perspectives to the Experian plc Board."

 

Brian Cassin, Experian's Chief Executive Officer said "Kerry, Craig and Jennifer are extraordinary leaders and we are fortunate to have access to talent of this calibre so widely across Experian. Kerry has played a pivotal role in taking the business to the strong position it is in today. We thank him for this and wish him well for his retirement. Craig and Jennifer will build on these strong foundations as we progress our journey of innovation-led growth and I look forward to continuing to work closely with them in the years to come."

 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6) in respect of the appointment of Craig Boundy as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4278

Gerry Tschopp Media queries

 

Tulchan

Graeme Wilson, Louise Male and Guy Bates +44 (0)20 7353 4200

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 20,000 people operating across 44 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWAWRUWUAAAR
Date   Source Headline
19th Jul 202312:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSTrading update, first quarter
12th Jul 20239:30 amRNSHolding(s) in Company
11th Jul 20234:00 pmRNSHolding(s) in Company
6th Jul 20233:00 pmRNSHolding(s) in Company
30th Jun 20235:32 pmRNSSecond Interim Dividend
30th Jun 202310:30 amRNSTotal Voting Rights
28th Jun 202310:00 amRNSAdditional Listing
23rd Jun 202310:00 amRNSDirector/PDMR Shareholding
22nd Jun 202310:55 amRNSDirector/PDMR Shareholding
21st Jun 202311:00 amRNSAdditional Listing
14th Jun 202312:00 pmRNSAdditional Listing
14th Jun 202310:00 amRNSDirector/PDMR Shareholding
9th Jun 20234:00 pmRNSAnnual Financial Report
7th Jun 20233:49 pmRNSDirector/PDMR Shareholding
2nd Jun 20239:00 amRNSElections for second interim dividend
31st May 20231:12 pmRNSTotal Voting Rights
31st May 20239:32 amRNSAdditional Listing
22nd May 202312:46 pmRNSDirector/PDMR Shareholding
18th May 20232:29 pmRNSDirector/PDMR Shareholding
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing
31st Mar 202311:35 amRNSTotal Voting Rights
29th Mar 20239:20 amRNSAdditional Listing
28th Mar 20237:00 amRNSDirectorate Change
22nd Mar 20235:19 pmRNSTransaction in Own Shares
22nd Mar 20239:15 amRNSAdditional Listing
20th Mar 20235:18 pmRNSTransaction in Own Shares
17th Mar 20235:31 pmRNSTransaction in Own Shares
16th Mar 20235:09 pmRNSTransaction in Own Shares
16th Mar 20239:15 amRNSBlock listing Interim Review
15th Mar 20235:14 pmRNSTransaction in Own Shares
15th Mar 20239:15 amRNSAdditional Listing
14th Mar 20235:21 pmRNSTransaction in Own Shares
13th Mar 20235:31 pmRNSTransaction in Own Shares
10th Mar 20236:10 pmRNSTransaction in Own Shares
9th Mar 20235:22 pmRNSTransaction in Own Shares
8th Mar 20235:21 pmRNSTransaction in Own Shares
8th Mar 20239:15 amRNSAdditional Listing
7th Mar 20235:26 pmRNSTransaction in Own Shares
1st Mar 202312:00 pmRNSDirector/PDMR Shareholding
1st Mar 20239:15 amRNSAdditional Listing
28th Feb 202312:20 pmRNSTotal Voting Rights
22nd Feb 202310:00 amRNSAdditional Listing
15th Feb 202310:45 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.